Duloxetine Delayed-Release Capsules
The FDA has issued a Class II recall for thousands of bottles of Duloxetine Delayed-Release Capsules, an antidepressant used to treat depression, anxiety, and nerve pain. The recall is due to the presence of N-nitroso-duloxetine, a potential cancer-causing chemical, found at higher-than-acceptable levels in the medication.
Steps to take if prescribed this medication
While this chemical is commonly found in low levels in food and water, excessive exposure can be harmful. The FDA is investigating the source of the contamination and advises patients currently taking the recalled medication not to discontinue use without first consulting a healthcare professional.
Ensuring Patient Safety
Patients are encouraged to discuss their concerns and explore alternative treatment options with their doctors. This recall highlights the importance of ongoing safety monitoring for medications to ensure patient well-being.
Source: FDA Enforcement Report
